Last $14.75 USD
Change Today +0.13 / 0.89%
Volume 64.2K
ANGO On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

angiodynamics inc (ANGO) Snapshot

Open
$14.68
Previous Close
$14.62
Day High
$14.89
Day Low
$14.56
52 Week High
01/10/14 - $19.00
52 Week Low
08/30/13 - $10.84
Market Cap
522.4M
Average Volume 10 Days
116.8K
EPS TTM
$0.25
Shares Outstanding
35.4M
EX-Date
--
P/E TM
59.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for ANGIODYNAMICS INC (ANGO)

angiodynamics inc (ANGO) Related Businessweek News

No Related Businessweek News Found

angiodynamics inc (ANGO) Details

AngioDynamics, Inc. designs, manufactures, and sells medical, surgical, and diagnostic devices. The company offers manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers, and interventional accessories that help clinicians in the diagnosis and treatment of cardiovascular and peripheral vascular diseases; and venous products, including laser system products used in endovascular laser procedures to treat superficial venous diseases, as well as sclerosing drugs that are used in the treatment of small uncomplicated varicose veins of the lower extremities. It also provides angiographic catheters and guidewires used during peripheral vascular interventional procedures; venous drainage cannula intended for use as a venous drainage cannula during extracorporeal bypass and cardiopulmonary bypass circuit intended for use in procedures requiring extracorporeal circulatory support; and drainage products that drain abscesses and other fluid pockets. In addition, the company offers thrombolytic catheters that are used to deliver thrombolytic agents; renal infusion products to deliver drugs directly to the kidneys in order to prevent and treat acute kidney injuries; micro access sets for minimally-invasive procedures; dialysis catheters that provide short and long-term vascular access for dialysis patients; and peripherally inserted central catheters, implantable ports, and central venous catheters. Further, it provides radiofrequency ablation products, soft tissue surgical ablation products, and microwave ablation products. The company markets and sells its products to interventional radiologists, interventional cardiologists, vascular surgeons, and interventional and surgical oncologists directly in the United States; and directly and through distributors internationally. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

1,330 Employees
Last Reported Date: 08/14/13
Founded in 1988

angiodynamics inc (ANGO) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $568.6K
Chief Financial Officer, Executive Vice Presi...
Total Annual Compensation: $167.2K
Senior Vice President of Global Franchise, On...
Total Annual Compensation: $276.8K
Compensation as of Fiscal Year 2013.

angiodynamics inc (ANGO) Key Developments

AngioDynamics Inc. Announces U.S. Food and Drug Administration Clearance for Celerity Tip Location System

AngioDynamics Inc. announced the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Celerity tip location system. The Celerity System has been cleared by the FDA as an adjunct to aid in positioning Peripherally Inserted Central Catheters in adults by providing real time catheter tip location utilizing the patient's cardiac electrical activity. The Company expects to begin U.S. distribution in early July. In March, AngioDynamics announced an agreement to acquire regulatory control over the Celerity platform from the Company's business partner, Medcomp, and its development partner, after the FDA rejected Medcomp's initial 510(k) application.

AngioDynamics Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 01:00 PM

AngioDynamics Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 01:00 PM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Mark T. Frost, Chief Financial Officer, Executive Vice President and Treasurer.

AngioDynamics Inc. Names Howard W. Donnelly as Chairman of the Board of Directors

AngioDynamics announced Howard W. Donnelly, 52, has been named Chairman of the Board of Directors, effective immediately. Mr. Donnelly joined the AngioDynamics Board of Directors in March 2004 and is the President of Concert Medical LLC, a manufacturer of interventional medical devices. In addition, Mr. Donnelly is President and Chief Executive Officer of HydroCision Inc. From 1999 to 2002, he was President of Level 1 Inc. From 1990-99, Mr. Donnelly was employed at Pfizer Inc., with his last position being Vice President, Business Planning and Development, for Pfizer's Medical Technology Group from 1997-99.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANGO:US $14.75 USD +0.13

ANGO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Astronics Corp $53.47 USD -0.17
CTS Corp $18.34 USD +0.01
Key Tronic Corp $10.58 USD -0.06
Sparton Corp $27.28 USD +0.08
Sypris Solutions Inc $5.00 USD -0.04
View Industry Companies
 

Industry Analysis

ANGO

Industry Average

Valuation ANGO Industry Range
Price/Earnings 100.0x
Price/Sales 1.5x
Price/Book 1.0x
Price/Cash Flow 24.7x
TEV/Sales 1.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANGIODYNAMICS INC, please visit www.angiodynamics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.